Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The patent for semaglutide, the active ingredient in Novo Nordisk's weight-loss drugs Wegovy and Ozempic, expired in India in March, and by the end of 2026, it will expire in 10 countries, including Brazil, China, South Africa, Turkey, and Canada
Out-of-pocket medication prices typically range from around $349 for lower doses of Zepbound to ~$935 per month for Ozempic if not covered by insurance
Medical reasons Pregnancy planning is a significant one
Formulated in Germany with 99.8% purity, this treatment ensures both safety and effectiveness
US$ 28.44
US$ 29.43
US$ 27.06
US$ 25.67
